|
|
Antibody Market Research
 | |  |
| |
Global Information, Inc. offers market intelligence on every topic in the Antibody Market, including, but not limited to: Therapeutic Antibodies; Immunomodulator; Monoclonal Antibody; Tumor Antigen; Immunotherapy.
We offer market research, industry forecasts, and business analysis in the Antibody Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
Reports
| Autoimmune And Inflammation Allergy |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Allergy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest new ... |
| Autoimmune And Inflammation Arthritis |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Arthritis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest ... |
| Autoimmune And Inflammation Autoimmune Diseases |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Autoimmune Diseases contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of t ... |
| Autoimmune And Inflammation Inflammation |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Inflammation contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the late ... |
| Autoimmune And Inflammation Lupus |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Lupus contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news ... |
| Autoimmune And Inflammation Rheumatoid Arthritis |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Rheumatoid Arthritis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of ... |
| Autoimmune And Inflammation Transplant Rejection or Transplantation |
|
| Published : 2008/03 |
| Life Science Analytics' , Autoimmune And Inflammation Transplant Rejection or Transplantation contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as we ... |
| ANGIOGENESIS MODULATORS - A MARKET INSIGHT REPORT |
|
| Published : 2008/01 |
| The study focuses on major angiogenesis inhibitors and their role in diseases such as cancer, dermatology, ophthalmology, rheumatology and other angiogenesis based diseases including endometriosis and inflammatory diseases. ... |
| APOPTOSIS - A MARKET INSIGHT REPORT |
|
| Published : 2008/01 |
| This market insight report gives an insight into Apoptosis Molecular Pathways - Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators and p53 Modulators. ... |
| Next-Generation Biologics: Improving on Monoclonal Antibodies |
|
| Published : 2007/12 |
| Monoclonal antibodies (MAbs) have become the most successful platform for targeted biotherapeutics, demonstrating high affi nity and specifi city for their target and considerably lower toxicity than small-molecule drugs. ... |
| Antibody Drug Target Atlas in Oncology |
|
| Published : 2007/06 |
| The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy in cancer. ... |
| BOTULINUM TOXIN |
|
| Published : 2007/06 |
| This report analyzes the worldwide markets for Botulinum Toxin in Millions of US$. The end-use segments analyzed are Cosmetic Applications, and Therapeutic Applications. The report provides separate comprehensive analytics for the USA, Japan, Europe, and ... |
| Monoclonal Antibodies Report Market Model |
|
| Published : 2007/06 |
| The model provides a comprehensive analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing trends by product, company, therapy area, technology and target type. It also provides an insight into the direction of mAb techn ... |
| Monoclonal Antibodies Report Part I |
|
| Published : 2007/06 |
| The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2012 and assessing trends by product, company, therapy area, technology and target type. It also provides an insight into t ... |
| Anti Infectives, Vol II: Antibacterials |
|
| Published : 2007/04 |
| Antibacterial drugs have turned bacterial infections into treatable ailments rather than the life-threatening conditions they once were. But the effectiveness of many antibiotics is being reduced as more and more types of bacteria become resistant to them ... |
| Immunotherapy in Oncology: Gaining Momentum |
|
| Published : 2006/08 |
| The immunotherapy field in cancer has never been more potent than it is right now, including block buster drugs like Avastin, Erbitux, and Rituxan. ... |
| Monoclonal Antibody Based Products |
|
| Published : 2006/08 |
| This report analyzes the worldwide markets for Monoclonal Antibody Based Products in Millions of US$. The major product segments analyzed are Therapeutics, and Diagnostics. The sub product segments analyzed include Cancer, and Others. The report provides ... |
| Triple Analysis: Melanoma, Antibodies and Vaccines in Oncology |
|
| Published : 2006/08 |
| In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Melanoma Therapeutics, Antibodies and Vaccines in Oncology, which are all subjects to an extensive number of innovative drug candidates. ... |
| Triple Progress Analysis: Lymphoma, PK Inhibitors & Antibodies |
|
| Published : 2006/05 |
| In this triple analysis report BioSeeker Group has analyzed three major and intertwined areas of cancer R&D, Lymphoma, Protein Kinase Inhibitors and Therapeutic Antibodies, which are all subjects to an extensive number of innovative drug candidates. ... |
| Monoclonal Antibodies in Asthma: The choice between life and breath? |
|
| Published : 2006/02 |
| Although only 5% of asthma suffers have severe asthma, these patients account for a disproportionately high percentage of healthcare spending, as asthma-related hospitalizations and emergency room visits are two of the costliest outcomes, which highlights ... |
| Antibody Technology Developments |
|
| Published : 2005/09 |
| The limited efficacy of conventional therapies, especially in the case of several autoimmune and inflammatory disorders, is creating a strong demand for safe and effective alternate treatments. ... |
| In-vitro Diagnostics--Industry Impact |
|
| Published : 2005/09 |
| End-user skepticism regarding the reliability of new assays for in-vitro diagnostics can be remedied with effective demonstrations and customer education about their remarkable benefits. ... |
| Dynamic Antibody Industry |
|
| Published : 2005/08 |
| Monoclonal antibody drugs offer several advantages over other types of drugs. Technologically, antibodies exhibit amazing specificity that allows for a safe and targeted attack on disease-causing cells or compounds. ... |
| U.S. Therapeutic Monoclonal Antibodies Markets |
|
| Published : 2005/05 |
| The shortage of reliable conventional therapies for critical illnesses is propelling demand for monoclonal antibodies (mAbs), which work closely with the bodys natural biomedical systems. ... |
|
|
View Cart
